Medical Condition News

RSS

Scientists validate new system for identifying individuals with preclinical Alzheimer's disease

For years, scientists have attempted to understand how Alzheimer's disease harms the brain before memory loss and dementia are clinically detectable. Most researchers think this preclinical stage, which can last a decade or more before symptoms appear, is the critical phase when the disease might be controlled or stopped, possibly preventing the failure of memory and thinking abilities in the first place.

24 Sep 2013

New diagnostic criteria for TSC appear in recent online issue of Pediatric Neurology

A paper detailing new diagnostic criteria for tuberous sclerosis complex (TSC) appears in the most recent online issue of Pediatric Neurology. The author is Hope Northrup, M.D., professor of pediatrics at The University of Texas Health Science Center at Houston (UTHealth).

24 Sep 2013

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

Respicardia, a developer of implantable therapies to improve respiratory and cardiovascular health, announced results from the remede System Pilot Study during the Heart Failure Society of America Late Breaking Scientific Session in Orlando. Dr. William T. Abraham of The Ohio State University Wexner Medical Center in Columbus presented the results for the first and only implantable device for respiratory rhythm management to treat central sleep apnea.

24 Sep 2013

Researchers discover drug that halts growth of brain tumor cells

Working with mice, Johns Hopkins researchers have discovered that weeks of treatment with a repurposed FDA-approved drug halted the growth of - and ultimately left no detectable trace of - brain tumor cells taken from adult human patients.

24 Sep 2013

Researchers reveals key role for stem cells that promote inflammation in atherosclerosis

University at Buffalo translational researchers are developing a richer understanding of atherosclerosis in humans, revealing a key role for stem cells that promote inflammation.

24 Sep 2013

Addition of walnuts to diet can protect against diabetes and heart disease in at-risk individuals

Medical researchers from the Yale-Griffin Prevention Research Center in Connecticut have found evidence suggestive that adding walnuts to one's diet can protect against diabetes and heart disease in at-risk individuals.

24 Sep 2013

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Janssen Biotech, Inc., announced today that the U.S. Food and Drug Administration (FDA) has approved STELARA® (ustekinumab) alone or in combination with methotrexate for the treatment of adult patients (18 years or older) with active psoriatic arthritis.

23 Sep 2013

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Lpath, Inc., the industry leader in lipidomics-based therapeutics, announced receipt of a Notice of Grant Award from the National Institutes of Health (NIH). This $145,000 Phase 1 SBIR grant will support the study of Lpath's therapeutic monoclonal antibody, Lpathomab™, in animal models of diabetic neuropathic pain and diabetic neuropathy.

23 Sep 2013

Researchers lead two major trials to test potential treatments for asbestos-related cancer

University of Leicester researchers are leading two major trials into treatments for a type of cancer which affects those exposed to asbestos.

23 Sep 2013

HP launches new CDC-recognized Diabetes Prevention Program for Bronx residents

Health People (HP) announced today the launch of its new Centers for Disease Control and Prevention (CDC)-recognized Diabetes Prevention Program for Bronx residents to help the borough combat its high diabetes-related death rate - the highest in the city.

23 Sep 2013

Almirall and GKV-SV reach agreement on pricing of Sativex medicine in Germany

...

23 Sep 2013

Apple impregnated with tangerine juice reduces risk of cardiovascular disease in obese children

Researchers at the Universitat de València, Universitat Politècnica de València (UPV), Doctor Peset University Hospital and the Institute of Agrochemistry and Food Technology of CSIC have designed and tested the effectiveness of a new apple snack impregnated with tangerine juice that reduces the risk of cardiovascular disease in obese children and improves their physiological well-being.

23 Sep 2013

Undersize school chairs, low desks and overweight backpacks contribute to chronic back pain in adolescents

Undersize school chairs, low desks and overweight backpacks are contributing to chronic back pain in adolescents, according to a study from researchers in Portugal to be published in the International Journal of Human Factors and Ergonomics.

23 Sep 2013

New research chair established to develop innovative strategies for Alzheimer's disease

On September 19, INRS director general Daniel Coderre and INRS-Institut Armand-Frappier Centre director Charles M. Dozois announced the creation of the Louise and André Charron Research Chair in Alzheimer's Disease.

23 Sep 2013

Older women with newly diagnosed breast cancer are more likely to experience functional disability

Many older women with newly diagnosed breast cancer have difficulty accomplishing daily tasks, and African-Americans seem to be disproportionately affected.

23 Sep 2013

Study explains why survival is low in peritoneal dialysis patients

Clinicians and scientists from Keele and Cardiff universities have published data from a landmark study that explains why survival in patients on peritoneal dialysis is low.

23 Sep 2013

New regulatory mechanism could help develop novel therapies for cancer

Molecular microbiologists at the University of Southern California (USC) have uncovered intricate regulatory mechanisms within the cell that could lead to novel therapeutics for the treatment of cancer and other diseases.

23 Sep 2013

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Ablynx and AbbVie today announced that they have entered into a global license agreement to develop and commercialize the anti-IL-6R Nanobody, ALX-0061, to treat inflammatory diseases.

23 Sep 2013

Researchers report encouraging results from T1DAL study on type 1 diabetes

Encouraging results from the T1DAL study (Targeting effector memory T cells with alefacept in new onset type 1 diabetes), led by Mark R. Rigby MD, PhD from Indiana University and Riley Hospital for Children in Indianapolis and sponsored by the Immune Tolerance Network (ITN) with additional support from JDRF, are published today in The Lancet Diabetes & Endocrinology.

23 Sep 2013

HFSA’s Annual Scientific Meeting focuses on ways to prevent heart failure

The 17th Annual Scientific Meeting of the Heart Failure Society of America (HFSA) will feature a session today entitled "The Prevention of Heart Failure." The session is being presented by HFSA and the American Heart Association.

23 Sep 2013

Medical Condition News

Scientists validate new system for identifying individuals with preclinical Alzheimer's disease

New diagnostic criteria for TSC appear in recent online issue of Pediatric Neurology

Respicardia reports results from remede System Pilot Study for central sleep apnea treatment

Researchers discover drug that halts growth of brain tumor cells

Researchers reveals key role for stem cells that promote inflammation in atherosclerosis

Addition of walnuts to diet can protect against diabetes and heart disease in at-risk individuals

FDA approves STELARA (Ustekinumab) for treatment of active psoriatic arthritis

Lpath receives NIH SBIR grant to investigate effect of Lpathomab compound on diabetic neuropathy

Researchers lead two major trials to test potential treatments for asbestos-related cancer

HP launches new CDC-recognized Diabetes Prevention Program for Bronx residents

Almirall and GKV-SV reach agreement on pricing of Sativex medicine in Germany

Apple impregnated with tangerine juice reduces risk of cardiovascular disease in obese children

Undersize school chairs, low desks and overweight backpacks contribute to chronic back pain in adolescents

New research chair established to develop innovative strategies for Alzheimer's disease

Older women with newly diagnosed breast cancer are more likely to experience functional disability

Study explains why survival is low in peritoneal dialysis patients

New regulatory mechanism could help develop novel therapies for cancer

Abbvie, Ablynx ink license agreement to develop anti-IL-6R Nanobody against inflammatory diseases

Researchers report encouraging results from T1DAL study on type 1 diabetes

HFSA’s Annual Scientific Meeting focuses on ways to prevent heart failure

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest News